IMV Inc. (IMVIF)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 37.7 Million USD | -5.0% |
| 2021 | 39.69 Million USD | 13.81% |
| 2020 | 34.87 Million CAD | 58.62% |
| 2019 | 21.98 Million CAD | 38.84% |
| 2018 | 15.83 Million USD | 62.24% |
| 2017 | 9.76 Million USD | 59.07% |
| 2016 | 6.13 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 Q4 | 8.61 Million USD | -6.58% |
| 2022 FY | 37.7 Million USD | -5.0% |
| 2022 Q1 | 10.57 Million USD | -7.0% |
| 2022 Q2 | 10.36 Million USD | -2.03% |
| 2022 Q3 | 9.21 Million USD | -11.02% |
| 2021 Q3 | 10.69 Million USD | 0.0% |
| 2021 FY | 39.69 Million USD | 13.81% |
| 2021 Q4 | 11.37 Million USD | 6.28% |
| 2020 FY | 34.87 Million CAD | 58.62% |
| 2019 FY | 21.98 Million CAD | 38.84% |
| 2018 FY | 15.83 Million USD | 62.24% |
| 2017 FY | 9.76 Million USD | 59.07% |
| 2016 FY | 6.13 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -2723.749% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -647.895% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -27.599% |
| Nascent Biotech, Inc. | 2.22 Million USD | -1591.088% |
| Rebus Holdings, Inc. | 664 Thousand USD | -5579.099% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -1.217% |
| Qrons Inc. | 643.67 Thousand USD | -5758.406% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -9579.801% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 34.35% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -8976.082% |
| Skye Bioscience, Inc. | 13.54 Million USD | -178.347% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 56.549% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -666.773% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -14307.898% |
| SQZ Biotechnologies Company | 85.61 Million USD | 55.957% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -1193.079% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -2410.769% |
| Mesoblast Limited | 5.9 Million USD | -538.923% |
| Marizyme, Inc. | 19.23 Million USD | -95.996% |
| Genus plc | 147.7 Million USD | 74.469% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -329.527% |
| Pharming Group N.V. | 225.49 Million USD | 83.277% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -1740.637% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -2710.88% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -352.203% |
| ContraFect Corporation | 56.88 Million USD | 33.714% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -755.342% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -2450.07% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -1251.412% |
| MultiCell Technologies, Inc. | 567.42 USD | -6645632.438% |
| ONE Bio Corp. | 6.44 Million USD | -485.193% |
| Accustem Sciences Inc. | 3.74 Million USD | -906.54% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 56.124% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -6988.705% |
| Q BioMed Inc. | 3.43 Million USD | -997.274% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -52.576% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -1335.163% |
| Biomind Labs Inc. | 994.18 Thousand USD | -3692.989% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 62.036% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -2042.961% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -461.315% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -1922.625% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 150936.86% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -135.532% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -1954.892% |
| GB Sciences, Inc. | 1.42 Million USD | -2554.627% |
| Alpha Cognition Inc. | 9.7 Million USD | -288.53% |
| HST Global, Inc. | 140.9 Thousand USD | -26661.775% |
| CSL Limited | 3.44 Billion USD | 98.907% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -3252.198% |
| Halberd Corporation | 74.84 Thousand USD | -50285.098% |
| Enzolytics Inc. | 2.17 Million USD | -1630.172% |
| Agentix Corp. | 1.37 Million USD | -2648.974% |
| Resverlogix Corp. | 12.71 Million USD | -196.643% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -932.929% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 97.541% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -3511.994% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -1467.994% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -2287.634% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -1007.473% |
| AVAX Technologies, Inc. | 7.31 Million USD | -415.839% |
| Zenith Capital Corp. | 8.94 Million USD | -321.662% |
| Genscript Biotech Corporation | 825.34 Million USD | 95.431% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -216358.384% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -1435.819% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -21886.727% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -1863.095% |
| Kadimastem Ltd | 2.41 Million USD | -1464.625% |
| Helix BioMedix, Inc. | 1.97 Million USD | -1812.199% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -247.007% |
| BioStem Technologies, Inc. | 22.97 Million USD | -64.133% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -20678.144% |
| LadRx Corporation | 3.81 Million USD | -889.278% |
| Cell Source, Inc. | 4.32 Million USD | -771.82% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3983.249% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3983.249% |
| NovAccess Global Inc. | 2.46 Million USD | -1428.693% |
| Affymax, Inc. | 39.38 Million USD | 4.257% |
| Itoco Inc. | 919.14 Thousand USD | -4002.649% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -789.701% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -3269.903% |
| Mobile Lads Corp. | 554.54 Thousand USD | -6700.016% |
| CytoDyn Inc. | 18.05 Million USD | -108.823% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -149724.049% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -17034.477% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -2555.968% |
| SYBLEU INC | 160.87 Thousand USD | -23339.926% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -1976.133% |
| International Stem Cell Corporation | 5.27 Million USD | -615.409% |
| Bioxytran, Inc. | 3.82 Million USD | -887.114% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -71533.325% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -185267.03% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -3.98% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -2230.607% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -5024.684% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -1112.125% |
| Neutra Corp. | 243.82 Thousand USD | -15365.942% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -116.012% |
| PureTech Health plc | 144.59 Million USD | 73.921% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -84.038% |
| IXICO plc | 4.7 Million USD | -701.131% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -328.66% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 67.975% |
| CSL Limited | 3.89 Billion USD | 99.031% |
| Cellectis S.A. | 97.32 Million USD | 61.252% |